Kabra Drugs Ord Shs (524322) Stock Price & News

All values in INR	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	197,64 m	304,20 m	354,06 m	462,17 m
Cost of goods sold	165,24 m	273,24 m	331,18 m	430,02 m
Cost of revenue	165,24 m	273,24 m	331,18 m	430,02 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3,57 m	3,85 m	4,49 m	2,37 m
Operating expense	12,14 m	6,77 m	9,59 m	4,46 m
Total operating expenses	177,38 m	280,01 m	340,77 m	434,48 m
Operating income	20,26 m	24,19 m	13,29 m	27,69 m
Other non operating income	1,79 m	1,84 m	-3,79 m	765,00 k
EBT including unusual items	22,05 m	26,01 m	14,15 m	28,40 m
EBT excluding unusual items	22,05 m	26,01 m	14,15 m	28,40 m
Income tax expense	3,68 m	341,00 k	3,58 m	7,17 m
Effective tax rate	16,70%	1,31%	25,34%	25,25%
Other operating expenses	8,45 m	2,79 m	4,67 m	1,88 m
Net income	18,37 m	25,66 m	10,56 m	21,23 m
Net profit margin	9,29%	8,44%	2,98%	4,59%
Earnings per share	-	-	-	-
Interest and investment income	-	-	4,93 m	-
Interest expense	-	-25,00 k	-275,00 k	-53,00 k
Net interest expenses	-	-25,00 k	4,65 m	-53,00 k
Depreciation and amortization charges	120,00 k	127,00 k	430,00 k	206,00 k
EBITDA	20,34 m	24,21 m	13,38 m	27,78 m
Gain or loss from assets sale	-	-	-	-

Finance